Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters











Publication year range
1.
Lett Appl Microbiol ; 75(4): 796-803, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35687081

ABSTRACT

Violacein is an important natural antimicrobial pigment that is mainly produced by Chromobacterium violaceum and Janthinobacterium lividum. It presents a significant range of effects against phytopathogenic and human fungi, besides being featured as having low toxicity, and by its important ecological role in protecting amphibian species and applications in dyed medical fabric. The hypothesis about violacein's action mechanisms against mucormycosis (Rhizopus arrhizus) and candidiasis (Candida auris) is herein discussed based on data available in the scientific literature.


Subject(s)
Anti-Infective Agents , Antifungal Agents , Antifungal Agents/pharmacology , Chromobacterium , Fungi , Humans , Indoles
2.
Colloids Surf B Biointerfaces ; 202: 111710, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33765626

ABSTRACT

The development of versatile carriers to deliver chemotherapeutic agents to specific targets with establishing drug release kinetics and minimum undesirable side effects is becoming a promising relevant tool in the medical field. Magnetic hybrid nanostructured lipid carriers (NLC) were prepared by incorporation of 1,8-cineole (CN, a monoterpene with antiproliferative properties) and maghemite nanoparticles (MNPs) into a hybrid matrix composed of myristyl myristate coated with chitosan. Hybrid NLC characterized by DLS and TEM confirmed the presence of positively charged spherical nanoparticles of around 250 nm diameter and +10.2 mV of Z-potential. CN encapsulation into the lipid core was greater than 75 % and effectively released in 24 h. Modification of the crystalline structure of nanoparticles after incorporation of CN and MNPs was observed by XRD, DSC, and TGA analyses. Superparamagnetic NLC behavior was verified by recording the magnetization using a vibrating scanning magnetometer. NLC resulted in more cytotoxic than free CN in HepG2 and A549 cell lines. Particularly, viability inhibition of HepG2 and A549 cells was increased from 35 % to 55 % and from 38 % to 61 %, respectively, when 8 mM CN was incorporated into the lipid NPs at 24 h. Green fluorescent-labeled NLC with DIOC18 showed an enhanced cellular uptake with chitosan-coated NLC. Besides, no cytotoxicity of the formulations in normal WI-38 cells was observed, suggesting that the developed hybrid NLC system is a safe and good potential candidate for the selective delivery and potentiation of anticancer drugs.


Subject(s)
Antineoplastic Agents , Nanoparticles , Nanostructures , Antineoplastic Agents/pharmacology , Drug Carriers , Eucalyptol , Lipids , Magnetic Phenomena , Particle Size
3.
Int J Pharm ; 569: 118575, 2019 Oct 05.
Article in English | MEDLINE | ID: mdl-31356956

ABSTRACT

In the global context of an imminent emergence of multidrug-resistant microorganisms, the present work combined the use of nanotechnology and the therapeutic benefits of natural compounds as a strategy to potentiate antimicrobial action of the wide-spectrum antibiotic Ofloxacin (Ofx). Hybrid solid lipid nanoparticles (SLN) were synthesized by incorporation of chitosan (Chi, a cationic biopolymer with antimicrobial activity) and eugenol (Eu, a phenolic compound that interferes with bacterial quorum sensing) into a lipid matrix by hot homogenization/ultrasonication method. The developed SLN/Chi/Eu sustainably released the encapsulated Ofx for 24 h. Characterization by DLS, TEM, DSC, TGA and XRD revealed the presence of positively charged spherical nanoparticles with diameters around 300 nm and Ofx entrapped in amorphous state. The SLN exhibited an enhanced bactericidal activity against Pseudomonas aeruginosa and Staphylococcus aureus. The minimum inhibitory concentration (MIC) for free and nanoencapsulated Ofx formulations was below 1.0 µg/ml. The MIC values decreased by 6.1- to 16.1-fold when Ofx was encapsulated in SLN/Chi/Eu. Fluorescent-labeled nanoparticles had the ability to interact with the bacterial cell membrane. Selective toxicity of SLN/Chi/Eu-Ofx was tested in the range of 0.3-30.0 µg/ml and showed no toxicity up to 3.0 µg/ml Ofx in human cell models (A549 and Wi-38) at 24 h and 48 h exposure. It was proved that the administration of hybrid SLN to mice by dry powder inhalation reached therapeutic Ofx levels in lungs.


Subject(s)
Anti-Infective Agents , Drug Carriers , Eugenol , Nanoparticles , Ofloxacin , A549 Cells , Animals , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacokinetics , Cell Survival/drug effects , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Drug Carriers/pharmacokinetics , Drug Liberation , Eugenol/administration & dosage , Eugenol/chemistry , Eugenol/pharmacokinetics , Humans , Lipids/administration & dosage , Lipids/chemistry , Lipids/pharmacokinetics , Lung/metabolism , Mice , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Ofloxacin/administration & dosage , Ofloxacin/chemistry , Ofloxacin/pharmacokinetics , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development
4.
Colloids Surf B Biointerfaces ; 170: 596-608, 2018 Oct 01.
Article in English | MEDLINE | ID: mdl-29975908

ABSTRACT

The use of hybrid materials, where a matrix sustains nanoparticles controlling the release of the chemotherapeutic drug, could be beneficial for the treatment of primary tumors prior or after surgery. This localized chemotherapy would guarantee high drug concentrations at the tumor site while precluding systemic drug exposure minimizing undesirable side effects. We combined bacterial cellulose hydrogel (BC) and nanostructured lipid carriers (NLCs) including doxorubicin (Dox) as a drug model. NLCs loaded with cationic Dox (NLCs-H) or neutral Dox (NLCs-N) were fully characterized and their cell internalization and cytotoxic efficacy were evaluated in vitro against MDA-MB-231 cells. Thereafter, a fixed combination of NLCs-H and NLCs-N loaded into BC (BC-NLCs-NH) was assayed in vivo into an orthotopic breast cancer mouse model. NLCs-H showed low encapsulation efficiency (48%) and fast release of the drug while NLCs-N showed higher encapsulation (97%) and sustained drug release. Both NLCs internalized via endocytic pathway, while allowing a sustained release of the Dox, which in turn rendered IC50 values below of those of free Dox. Taking advantage of the differential drug release, a mixture of NLCs-N and NLCs-H was encapsulated into BC matrix (BC-NLCs-NH) and assayed in vivo, showing a significant reduction of tumor growth, metastasis incidence and local drug toxicities.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Breast Neoplasms/drug therapy , Cellulose/chemistry , Doxorubicin/pharmacology , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Lipids/chemistry , Nanoparticles/chemistry , Acetobacteraceae/chemistry , Animals , Antibiotics, Antineoplastic/administration & dosage , Breast Neoplasms/pathology , Cell Proliferation/drug effects , Cell Survival/drug effects , Doxorubicin/administration & dosage , Drug Carriers/chemistry , Drug Delivery Systems , Drug Screening Assays, Antitumor , Female , Humans , Mammary Neoplasms, Experimental/drug therapy , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Nude , Particle Size , Surface Properties , Tumor Cells, Cultured
5.
Colloids Surf B Biointerfaces ; 167: 73-81, 2018 Jul 01.
Article in English | MEDLINE | ID: mdl-29627680

ABSTRACT

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) represent promising alternatives for drug delivery to the central nervous system. In the present work, four different nanoformulations of the antiepileptic drug Carbamazepine (CBZ) were designed and prepared by the homogenization/ultrasonication method, with encapsulation efficiencies ranging from 82.8 to 93.8%. The formulations remained stable at 4 °C for at least 3 months. Physicochemical and microscopic characterization were performed by photon correlation spectroscopy (PCS), transmission electron microscopy (TEM), atomic force microscopy (AFM); thermal properties by differential scanning calorimetry (DSC), thermogravimetry (TGA) and X-ray diffraction analysis (XRD). The results indicated the presence of spherical shape nanoparticles with a mean particle diameter around 160 nm in a narrow size distribution; the entrapped CBZ displayed an amorphous state. The in vitro release profile of CBZ fitted into a Baker-Lonsdale model for spherical matrices and almost the 100% of the encapsulated drug was released in a controlled manner during the first 24 h. The apparent permeability of CBZ-loaded nanoparticles through a cell monolayer model was similar to that of the free drug. In vivo experiments in a mice model of seizure suggested protection by CBZ-NLC against seizures for at least 2 h after intraperitoneal administration. The developed CBZ-loaded lipid nanocarriers displayed optimal characteristics of size, shape and drug release and possibly represent a promising tool to improve the treatment of refractory epilepsy linked to efflux transporters upregulation.


Subject(s)
Anticonvulsants/chemistry , Carbamazepine/chemistry , Lipids/chemistry , Nanoparticles/chemistry , Nanostructures/chemistry , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/pharmacokinetics , Calorimetry, Differential Scanning , Carbamazepine/administration & dosage , Carbamazepine/pharmacokinetics , Dogs , Drug Carriers/chemistry , Drug Delivery Systems/methods , Drug Liberation , Madin Darby Canine Kidney Cells , Mice , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Nanoparticles/ultrastructure , Nanostructures/ultrastructure , Particle Size , Thermogravimetry , X-Ray Diffraction
6.
J Mater Chem B ; 5(17): 3132-3144, 2017 May 07.
Article in English | MEDLINE | ID: mdl-32263711

ABSTRACT

Current medical treatments against recurrent pulmonary infections caused by Pseudomonas aeruginosa, such as cystic fibrosis (CF) disorder, involve the administration of inhalable antibiotics. The main challenge is, however, the eradication of microbial biofilms immersed in dense mucus that requires high and recurrent antibiotic doses. Accordingly, the development of novel drug delivery systems capable of providing local and controlled drug release in the lungs is a key factor to improve the therapeutic outcome of such therapeutic molecules. Inhalable hybrid carriers were prepared by co-precipitation of CaCO3 in the presence of alginate and the resulting microparticles were treated with alginate lyase (AL) in order to modify their porosity and enhance the drug loading. The hybrid microparticles were loaded with DNase (mucolytic agent) and levofloxacin (LV, wide-spectrum antibiotic) in the range of 20-40% for LV and 28-67% for DNase, depending on the AL treatment. In vitro studies demonstrated that microparticles were able to control the DNase release for 24 h, while 30-50% of LV was released in 3 days. The morphological characterization was performed by optical, fluorescence and scanning electron microscopies, showing a narrow size distribution (5 µm). FTIR, XRD, DSC and nitrogen adsorption isotherm studies revealed the presence of the drugs in a non-crystalline state. A microcidal effect of microparticles was found on P. aeruginosa in agar plates and corroborated by Live/Dead kit and TEM observations. Finally, to study whether the microparticles improved the localization of LV in the lungs, in vivo studies were performed by pulmonary administration of microparticles to healthy mice via nebulization and dry powder inhalation, followed by the quantification of LV in lung tissue. The results showed that microparticles loaded with LV delivered the antibiotic at least 3 times more efficiently than free LV. The developed system opens the gateway to new drug delivery systems that may provide enhanced therapeutic solutions against bacterial infections and in particular as a potential tool in CF pathology.

7.
J Colloid Interface Sci ; 439: 76-87, 2015 Feb 01.
Article in English | MEDLINE | ID: mdl-25463178

ABSTRACT

HYPOTHESIS: Biopolymer-CaCO3 hybrid microparticles exposed to hydrolytic enzymes can provide new surface tailorable architectures. Soluble Alginate Lyase hydrolyzed alginate chains exposed on microparticle surface are generating considerable matrix changes. The change of porosity and surface to volume ratio is expected to influence absorption of drugs, thereby affecting controlled release profiles. The developed hybrid system potentially shows interesting properties for lung drug administration. EXPERIMENTAL: Hybrid microparticles were developed by colloidal co-precipitation of CaCO3 in presence of biopolymers: alginate (Alg) or Alg-High Methoxylated Pectin (HMP), followed by treatment with Alginate Lyase (AL). Surface architectures were observed by SEM. The increase in area to volume ratio was confirmed by BET isotherms. Also, enzymatic changes were elucidated by biophysical methods (EDAX, DSC, FTIR, XRD) and determination of the total carbohydrates content. Levofloxacin (a fluoroquinolone antibiotic) as model drug was incorporated by absorption. The drug release profile and the antimicrobial activity of the microparticles were tested against Pseudomonas aeruginosa. FINDINGS: After enzyme treatment, microspheres showed 4µm diameter and increased porosity. While CaCO3-Alg microspheres resulted in a rougher surface, CaCO3-Alg-HMP ones exhibited "nano-balloon" patterns on surface. Both AL-treated microparticles showed up to 3 and 7 times higher Levofloxacin encapsulation than no treated ones. Microparticles showed controlled drug release profiles and enhanced antimicrobial effect. The present work demonstrates a significant progress in the development of new carriers with potential application for lung infections treatment.


Subject(s)
Calcium Carbonate/chemistry , Delayed-Action Preparations , Drug Delivery Systems/instrumentation , Nanoparticles/chemistry , Polysaccharide-Lyases/chemistry , Levofloxacin/pharmacology , Microscopy, Electron, Scanning , Nanotechnology , Particle Size , Surface Properties
8.
J Hazard Mater ; 175(1-3): 399-403, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-19896272

ABSTRACT

A method was developed to attach 4-amino-2-mercaptopyrimidine (AMP) onto silica gel surface and to determine trace metals. The surface functionalization reaction was performed with a silylant agent, chloropropyltrimethoxysilane (Si-CPTS), and the product, Si-AMP, was characterized by FT-IR and elemental analysis to evaluate the surface modification. The functionalized silica was applied in the sorption of Cu(II) ions from an aqueous medium. The series of adsorption isotherms were adjusted to a modified Langmuir equation and the maximum number of moles of adsorbed copper was 0.447 mmol g(-1). The modified material was placed in a preconcentration system, where it reached an approximately 20-fold enrichment factor using 5mg of Si-AMP. The proposed method was applied in the preconcentration and determination of Cu(II) in a fresh water sample from the Paraná river and was validated through a comparative analysis of a standard reference material (1643e).


Subject(s)
Copper/chemistry , Silicon Dioxide/chemistry , Solid Phase Extraction/methods , Water Pollutants, Chemical/isolation & purification , Water Purification/methods , Adsorption , Gels , Ions , Kinetics , Ligands , Pyrimidines/chemistry , Spectrophotometry, Atomic/methods , Spectroscopy, Fourier Transform Infrared/methods , Sulfhydryl Compounds/chemistry , Water Pollutants, Chemical/chemistry
9.
Osteoporos Int ; 21(9): 1617-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-19936866

ABSTRACT

Zoledronic acid is effective for osteoporosis at a single annual intravenous dose. It usually causes few adverse effects; the most common are related to acute phase reactions. We reported the case of a 64-year-old woman who presented flare-up of hand osteoarthritis after zoledronic acid infusions. Despite the fact that arthralgia is a common side effect of intravenous bisphosphonates, development of inflammatory signs in osteoarthritic joints is a rare event. We hypothesized that this side effect is caused by a release of cytokines secondary to activation of gamma-delta T lymphocytes.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Hand Joints , Imidazoles/adverse effects , Osteoarthritis/chemically induced , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/drug therapy , Zoledronic Acid
10.
Appl Biochem Biotechnol ; 151(2-3): 578-86, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18543116

ABSTRACT

Lipase from Brevibacillus agri 52 was found stable up to 90% diethylenglycol (DEG), glycerol (GLY), and 1,2 propanediol (1,2 PRO) at 37 degrees C for 1 h and the stability was reduced only approximately 20% after 12 h incubation, but in 40% dimethylsulfoxide (DMSO), lipase activity was stable only for 1 h. Inhibition of the biocatalysts with dimethylformamide (DMF) was detected at 20% solvent concentration. In water immiscible systems, the stability of lipase in n-hexane, n-tetradecane and n-heptane resembles the water activity, but in the presence of isobutanol, 1-hexanol, and butylbutirate, the stability was significantly reduced. Lipase 52 precipitates in the presence of 50% acetone or ethanol/water mixtures, but enzymatic activity was partially recovered by adding 20% GLY, DEG, 1,2 PRO, or DMSO to the reaction mixture. Furthermore, by increasing DEG in 70% DMF/DEG mixtures, the lipase activity was protected. Encapsulation of lipase in pectin gels cross-linked with calcium ions brings three to four times more enzymatic activity in 70% water miscible organic solvents compared to aqueous systems.


Subject(s)
Enzymes, Immobilized/drug effects , Lipase/drug effects , Solvents/pharmacology , Alcohols/pharmacology , Dimethyl Sulfoxide/pharmacology , Dimethylformamide/pharmacology , Enzyme Stability , Ethylene Glycols/pharmacology , Glycerol/pharmacology , Gram-Positive Endospore-Forming Rods/enzymology , Lipase/antagonists & inhibitors , Microspheres , Pectins , Propylene Glycol/pharmacology
11.
J Basic Microbiol ; 46(5): 348-57, 2006.
Article in English | MEDLINE | ID: mdl-17009290

ABSTRACT

Gamma-hexachlorocyclohexane (gamma-HCH or lindane), one of the most commonly used pesticides, has been mainly used in agriculture; this pesticide is known to be highly toxic and persistent, causing serious water and soil contamination. The objective of the present work is to study the effect of low glucose concentration and the addition of lindane at different growing time on the pesticide detoxification ability of Streptomyces M7. After 96 h of incubation in synthetic medium containing glucose 0.6 g l(-1) with the addition of lindane 100 microg l(-1) at 20 h of incubation, a typical diauxic curve was obtained: glucose was the preferred substrate until 24 h, at 48 h, when the carbohydrate was depleted, the microorganism consumed the pesticide like carbon source. On the other hand, lindane removal induction was observed, which was greater when the pesticide was added to the medium at 20 h than 6 h of incubation. Between 72 and 96 h, a maximum of approximately 86% of the Cl(-) was released when lindane was added to the medium at 20 h, whereas approximately 70% and 67% Cl(-) was released in the medium when the pesticide was added at 0 and 6 h of incubation respectively. This is the first report of chloride release from inoculated medium supplemented with lindane, suggesting that the pesticide was degraded by Streptomyces sp. under aerobic conditions.


Subject(s)
Hexachlorocyclohexane/metabolism , Insecticides/metabolism , Streptomyces/metabolism , Biodegradation, Environmental , Chlorides/metabolism , Culture Media , Ecosystem , Geologic Sediments/microbiology , Glucose/metabolism , Streptomyces/growth & development , Streptomyces/isolation & purification
12.
Anal Bioanal Chem ; 375(8): 1097-100, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12733022

ABSTRACT

In this work the copper(II) complexation parameters of aquatic organic matter, aquatic and soil humic substances from Brazilian were determined using a new versatile approach based on a single-stage tangential-flow ultrafiltration (TF-UF) technique (cut-off 1 kDa) and sensitive atomic spectrometry methods. The results regarding the copper(II) complexation capacity and conditional stability constants obtained for humic materials were compared with those obtained using direct potentiometry with a copper-ion-selective electrode. The analytical procedure based on ultrafiltration is a good alternative to determine the complexation parameters in natural organic material from aquatic and soil systems. This approach presents additional advantages such as better sensibility, applicability for multi-element capability, and its possible to be used under natural conditions when compared with the traditional ion-selective electrode.


Subject(s)
Soil/analysis , Ultrafiltration/methods , Water/chemistry , Brazil , Copper/chemistry , Ions
13.
Bioresour Technol ; 89(2): 133-8, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12699931

ABSTRACT

Ninety-three wild-type isolates identified as actinomycetes were tested against 11 organochlorine pesticides (OPs): aldrin, chlordane, DDD, DDE, DDT, dieldrin, heptachlor, and heptachlor epoxides, lindane, and methoxychlor. Qualitative screening agar assays displayed 62-78% tolerance of strains to OPs. Four strains designed M4, M7, M9 and M15 were selected based on multi-OP-tolerance, and identified as members of the streptomycetes group. Different growth profiles were observed in cultures of the four selected streptomycetes cultured in synthetic medium containing 5-50 microg x l(-1) aldrin or chlordane or lindane. Increase of aldrin removal by the selected microorganisms was concomitant with the 4.8-36.0 microg x l(-1) pesticide concentration range. After 72 h of streptomycete M7 growth in synthetic medium containing 48.0 microg x l(-1) aldrin, the remaining OP concentration in the supernatant was approximately 10% of the initial concentration. Also, in stationary growth phase less than 2.5 microg x l(-1) aldrin residual concentration was detected in the medium.


Subject(s)
Hydrocarbons, Chlorinated , Insecticides/metabolism , Streptomycetaceae/physiology , Water Purification/methods , Biodegradation, Environmental , Streptomycetaceae/isolation & purification
14.
Anal Bioanal Chem ; 375(4): 574-7, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12610713

ABSTRACT

This work describes the synthesis and characterization of 2-aminothiazole-modified silica gel (SiAT), as well as its application for preconcentration (in batch and column technique) of Cu(II), Ni(II) and Zn(II) in ethanol medium. The adsorption capacities of SiAT determined for each metal ion were (mmol g(-1)): Cu(II)=1.20, Ni(II)=1.10 and Zn(II)=0.90. In addition, results obtained in flow experiments, showed a recovery of ca. 100% of the metal ions adsorbed in a column packed with 500 mg of SiAT. The eluent was 2.0 mol L(-1) HCl. The sorption-desorption of the studied metal ions made possible the development of a preconcentration method for metal ions at trace level in fuel ethanol using flame AAS for their quantification.


Subject(s)
Chromatography/methods , Ethanol/analysis , Metals, Heavy/analysis , Automobiles , Chelating Agents , Copper/analysis , Energy-Generating Resources , Nickel/analysis , Silica Gel , Silicon Dioxide , Thiazoles , Zinc/analysis
15.
FEMS Microbiol Lett ; 204(1): 33-8, 2001 Oct 16.
Article in English | MEDLINE | ID: mdl-11682174

ABSTRACT

Phosphatidylinositol-specific phospholipase C (PI-PLC) activity was investigated in 25 different lactic acid bacteria (LAB) strains belonging to the genera Lactobacillus, Weisella, and Enterococcus. PI-PLC activity was detected in 44% of the strains studied in culture medium without carbon source. From the PI-PLC positive strains, Lactobacillus rhamnosus ATCC 7469 was selected for translocation studies. Healthy mice were orally administered with a daily dose of 2.0 x 10(9) of viable L. rhamnosus suspension. Viable bacteria were detected in liver and spleen of mice fed with LAB for 7 days. Bacterial colonies isolated from liver were biochemically characterized, and further subjected to randomly amplified polymorphic DNA. Amplification patterns of five strains displayed identical profiles to L. rhamnosus. PI-PLC activity was determined in the strains recovered from liver.


Subject(s)
Bacterial Translocation , Lactobacillus/enzymology , Lactobacillus/physiology , Probiotics , Type C Phospholipases/metabolism , Animals , Humans , Lactobacillus/genetics , Lactobacillus/isolation & purification , Liver/microbiology , Mice , Mice, Inbred BALB C , Phosphatidylinositol Diacylglycerol-Lyase , Phosphoinositide Phospholipase C , Random Amplified Polymorphic DNA Technique , Spleen/microbiology
16.
J Ind Microbiol Biotechnol ; 26(4): 210-5, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11464268

ABSTRACT

Strains designated R22 and R25, isolated from Salí River sediments, Argentina, were highly resistant to chromium. These strains were shown by 16S rRNA sequencing studies to be Streptomyces spp.; this affiliation was consistent with morphological and chemical characteristics. Growth of strains R22 and R25 in medium containing 100 mg l(-1) chromate was reduced by only 23% and 34%, respectively, compared with growth in medium without added chromium. Streptomyces sp. strains R22 and R25 both accumulated chromium with yields of 10.0 and 5.6 mg Cr g(-1) of dry weight, respectively, and a chromate concentration of 50 mg ml(-1). Cell fractionation studies with strain R22 showed that the great majority of the chromium were associated with the cell wall fraction. Streptomyces strains R22 and R25 may have applications in bioremediation of chromium contamination.


Subject(s)
Chromium/metabolism , Geologic Sediments/microbiology , Streptomyces/isolation & purification , Streptomyces/metabolism , Biodegradation, Environmental , Chromium/toxicity , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Fresh Water/microbiology , Phylogeny , RNA, Ribosomal, 16S/genetics , Streptomyces/genetics , Streptomyces/growth & development , Water Microbiology , Water Pollution, Chemical
17.
Atherosclerosis ; 152(1): 181-92, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10996354

ABSTRACT

Hypertriglyceridemia is a complex pathological entity strongly connected to low HDL-C levels but controversially related to the risk of coronary artery disease. In this study, we evaluated the main steps of the antiatherogenic pathway called reverse cholesterol transport in a group of patients with primary hypertriglyceridemia and low HDL-C levels in comparison to normotriglyceridemic subjects with or without hypoalphalipoproteinemia. In patients with primary hypertriglyceridemia, low HDL-C levels were accompanied by decreased apo A-I and apo A-II concentrations. These reductions were manifested by a selective reduction in LpA-I:A-II particles. In addition, apo C-III Lp non B was found to be elevated and HDL lipid percentage composition showed a triglyceride enrichment and cholesterol depletion. The capacity of serum samples from hypertriglyceridemic patients to promote cellular cholesterol efflux was reduced, as evidenced by using two different cellular models, Fu5AH and J774 cells. This impaired cholesterol efflux promotion was also corroborated by incubations of isolated HDL fractions with Fu5AH cells. Lecithin:cholesterol acyltransferase (LCAT) activity, the driving force of reverse cholesterol transport, showed a tendency towards lower values in hypertriglyceridemic patients, but this difference was not statistically significant. Additionally, cholesteryl ester transfer protein (CETP) activity was increased in this group of patients. Therefore, hypertriglyceridemia was found to induce quantitative and qualitative alterations in HDL and its subclasses and, consequently, in some steps of reverse cholesterol transport. The abnormalities found in this antiatherogenic pathway and its promoters could constitute a possible connection between hypertriglyceridemia and atherosclerosis.


Subject(s)
Carrier Proteins/metabolism , Cholesterol, HDL/blood , Cholesterol/metabolism , Glycoproteins , Hypertriglyceridemia/metabolism , Phosphatidylcholine-Sterol O-Acyltransferase/metabolism , Adult , Aged , Biological Transport , Cholesterol Ester Transfer Proteins , Humans , Male , Middle Aged , Probability , Reference Values , Statistics, Nonparametric
18.
Medicina (B Aires) ; 59(1): 89-92, 1999.
Article in Spanish | MEDLINE | ID: mdl-10349128

ABSTRACT

This syndrome is a pathological entity of low incidence which mainly affects high density lipoprotein (HDL) metabolism. We here show the first case reported in our country, observed in a 63-year-old woman who showed bilateral corneal opacity and eruptive xanthomas in both arms. The lipoprotein profile disclosed severe hypertriglyceridemia and normocholesterolemia, although the percentage of cholesteryl esters was low. Plasma levels of HDL-cholesterol and HDL major apolipoproteins, A-I and A-II, were markedly decreased. The patient also showed glucose intolerance and hematological alterations related to abnormal lipid composition of erythrocyte membranes. As evaluated by the exogen substrate method, LCAT activity proved to be 82% lower in the patient than in a control subject. It is noteworthy that the patient had experienced cardiac events and presented hypertension, neither of which has been commonly documented in partial LCAT deficiency syndromes.


Subject(s)
Cholesterol, HDL/blood , Lecithin Cholesterol Acyltransferase Deficiency/blood , Female , Fenofibrate/therapeutic use , Humans , Lecithin Cholesterol Acyltransferase Deficiency/diagnosis , Lecithin Cholesterol Acyltransferase Deficiency/drug therapy , Middle Aged , Syndrome
19.
Clin Chim Acta ; 279(1-2): 1-14, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10064113

ABSTRACT

In this study, we first characterized the lipoprotein components of serum samples obtained from a group of well-controlled diabetic patients and from healthy subjects in fasting and postprandial states. We then explored some aspects of reverse cholesterol transport in the same population. Patients showed high levels of fasting triglycerides, postprandial triglyceride responses and LpC-III levels (3.18+/-0.86 vs 2.17+/-0.54 mg/dl, P < 0.001). There were also positive correlations between LpC-III and fasting triglycerides (r = 0.82, P < 0.001), total triglyceride area (r = 0.75, P < 0.001) and incremental triglyceride area (r = 0.54, P < 0.001). HDL-C and apo A-I were significantly decreased in diabetic patients due to a selective reduction in LpA-I subfraction, whose antiatherogenic role is generally accepted (37.4+/-8.0 vs 49.2+/-12.5 mg/dl, P < 0.001). In addition, HDL from patients proved to be triglyceride enriched and cholesteryl ester depleted, alterations which were further amplified in the postprandial state. The molar ratio HDL-C/apo A-I + apo A-II, already defined as a predictor of apo A-I fractional catabolic rate, was significantly diminished in the patient group (15.1+/-2.2 vs 20.8+/-3.3, P < 0.001), thus suggesting an accelerated catabolism of apo A-I. For the first time, we describe here the presence of a small apo A-I-containing particle, isolated by two-dimensional electrophoresis and characterized by immunoblotting, only in samples from diabetic patients. This particle that we named pre-beta0, has an apparent molecular weight of 40 kDa. As regards the capacity of serum samples to promote cholesterol efflux from [3H]cholesterol-labeled Fu5AH rat hepatoma cells, patient samples were found to induce significantly lower cholesterol efflux than controls only in the postprandial state (21.2+/-3.3 vs 23.8+/-1.8%, P = 0.012). The presence of pre-beta0 in samples from diabetic patients might therefore be associated to an altered capacity of these serum samples to promote cellular cholesterol efflux. Overall, these abnormalities may contribute to a delay in the reverse cholesterol transport pathway in type 2 diabetic patients.


Subject(s)
Cholesterol/blood , Diabetes Mellitus, Type 2/blood , Lipoprotein(a)/analogs & derivatives , Protein Precursors/blood , Adult , Animals , Apolipoprotein C-III , Apolipoproteins C/blood , Cholesterol/metabolism , Cholesterol, HDL/blood , Fasting/blood , Hemofiltration , Humans , Lipoprotein(a)/blood , Liver Neoplasms, Experimental/metabolism , Male , Middle Aged , Postprandial Period , Rats , Triglycerides/blood , Tumor Cells, Cultured
20.
Medicina (B.Aires) ; 59(1): 89-92, 1999.
Article in Spanish | BINACIS | ID: bin-40028

ABSTRACT

This syndrome is a pathological entity of low incidence which mainly affects high density lipoprotein (HDL) metabolism. We here show the first case reported in our country, observed in a 63-year-old woman who showed bilateral corneal opacity and eruptive xanthomas in both arms. The lipoprotein profile disclosed severe hypertriglyceridemia and normocholesterolemia, although the percentage of cholesteryl esters was low. Plasma levels of HDL-cholesterol and HDL major apolipoproteins, A-I and A-II, were markedly decreased. The patient also showed glucose intolerance and hematological alterations related to abnormal lipid composition of erythrocyte membranes. As evaluated by the exogen substrate method, LCAT activity proved to be 82


lower in the patient than in a control subject. It is noteworthy that the patient had experienced cardiac events and presented hypertension, neither of which has been commonly documented in partial LCAT deficiency syndromes.

SELECTION OF CITATIONS
SEARCH DETAIL